Literature DB >> 33302738

The neurovascular extracellular matrix in health and disease.

Aric F Logsdon1,2, Elizabeth M Rhea1,2, May Reed1,2, William A Banks1,2, Michelle A Erickson1,2.   

Abstract

The blood-brain barrier (BBB) is a vital interface that supports normal brain functions. Endothelial cells (ECs) are the main component of the BBB and are highly specialized to govern the transfer of substances into brain. The EC lumen is enmeshed with an extracellular matrix (ECM), known as the endothelial glycocalyx layer (EGL). The lumen-facing EGL is primarily comprised of proteoglycans (PGs) and glycosaminoglycans (GAGs), which function as the first line of defense for blood-to-brain transfer of substances. Circulating factors must first penetrate the EGL before interacting with the EC. The abundance and composition of the PG and GAGs can dictate EGL function, and determine which circulating substances communicate with the ECs. The EGL can interact with circulating factors through physio-chemical interactions with the EC. Some disease states reveal a "thinning" of the EGL that may increase EC interactions with components of the systemic circulation and alter BBB function. EGL changes may also contribute to the cognitive complications of systemic diseases, such as sepsis and diabetes. For decades, researchers have measured how genetic and environmental factors influence the peripheral EGL constituents; however, much less is known about the neurovascular EGL. In this mini-review, we introduce components of the EGL and innovative ways to measure their abundance and composition that may contribute to BBB dysfunction.

Entities:  

Keywords:  Glycocalyx; blood–brain barrier; extracellular matrix; glycosaminoglycans; proteoglycans

Mesh:

Year:  2020        PMID: 33302738      PMCID: PMC8719034          DOI: 10.1177/1535370220977195

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  117 in total

1.  Endothelial glycocalyx on brain endothelial cells is lost in experimental cerebral malaria.

Authors:  Casper Hempel; Poul Hyttel; Jørgen A L Kurtzhals
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-23       Impact factor: 6.200

2.  Glycosaminoglycans and atheroma in the iliac arteries.

Authors:  R N Mullinger; G Manley
Journal:  J Atheroscler Res       Date:  1967 May-Jun

3.  Hyaluronan impairs the barrier integrity of brain microvascular endothelial cells through a CD44-dependent pathway.

Authors:  Abraham J Al-Ahmad; Ronak Patel; Sean P Palecek; Eric V Shusta
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-28       Impact factor: 6.200

4.  Permeation of the luminal capillary glycocalyx is determined by hyaluronan.

Authors:  C B Henry; B R Duling
Journal:  Am J Physiol       Date:  1999-08

5.  Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library.

Authors:  Yumi Ito; Megumi Hikino; Yuki Yajima; Tadahisa Mikami; Swetlana Sirko; Alexer von Holst; Andreas Faissner; Shigeyuki Fukui; Kazuyuki Sugahara
Journal:  Glycobiology       Date:  2004-12-29       Impact factor: 4.313

6.  Mass spectral profiling of glycosaminoglycans from histological tissue surfaces.

Authors:  Chun Shao; Xiaofeng Shi; Joanna J Phillips; Joseph Zaia
Journal:  Anal Chem       Date:  2013-10-29       Impact factor: 6.986

7.  Quantification of blood-brain barrier solute permeability and brain transport by multiphoton microscopy.

Authors:  Lingyan Shi; Min Zeng; Yi Sun; Bingmei M Fu
Journal:  J Biomech Eng       Date:  2014-03       Impact factor: 2.097

8.  Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography-electrospray ionization-tandem mass spectrometry.

Authors:  Harumi Osago; Tomoko Shibata; Nobumasa Hara; Suguru Kuwata; Michihaya Kono; Yuji Uchio; Mikako Tsuchiya
Journal:  Anal Biochem       Date:  2014-09-06       Impact factor: 3.365

9.  Blood-brain barrier breakdown in the aging human hippocampus.

Authors:  Axel Montagne; Samuel R Barnes; Melanie D Sweeney; Matthew R Halliday; Abhay P Sagare; Zhen Zhao; Arthur W Toga; Russell E Jacobs; Collin Y Liu; Lilyana Amezcua; Michael G Harrington; Helena C Chui; Meng Law; Berislav V Zlokovic
Journal:  Neuron       Date:  2015-01-21       Impact factor: 17.173

Review 10.  Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment.

Authors:  Divine C Nwafor; Allison L Brichacek; Afroz S Mohammad; Jessica Griffith; Brandon P Lucke-Wold; Stanley A Benkovic; Werner J Geldenhuys; Paul R Lockman; Candice M Brown
Journal:  J Cent Nerv Syst Dis       Date:  2019-04-09
View more
  4 in total

1.  Viable human brain microvessels for the study of aging and neurodegenerative diseases.

Authors:  Mamatha Damodarasamy; Zin Z Khaing; Jeffrey Hyde; C Dirk Keene; Itay Bentov; William A Banks; May J Reed
Journal:  Microvasc Res       Date:  2021-11-20       Impact factor: 3.514

Review 2.  Surface charge, glycocalyx, and blood-brain barrier function.

Authors:  Fruzsina R Walter; Ana R Santa-Maria; Mária Mészáros; Szilvia Veszelka; András Dér; Mária A Deli
Journal:  Tissue Barriers       Date:  2021-05-18

Review 3.  Nanotherapeutics and the Brain.

Authors:  Andrea Joseph; Elizabeth Nance
Journal:  Annu Rev Chem Biomol Eng       Date:  2022-03-23       Impact factor: 9.700

Review 4.  Need for a Paradigm Shift in the Treatment of Ischemic Stroke: The Blood-Brain Barrier.

Authors:  Maria Luz Alonso-Alonso; Ana Sampedro-Viana; Sabela Fernández-Rodicio; Marcos Bazarra-Barreiros; Alberto Ouro; Tomás Sobrino; Francisco Campos; José Castillo; Pablo Hervella; Ramón Iglesias-Rey
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.